Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 58

Results For "EPS"

576 News Found

Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr
News | February 08, 2021

Jubilant Pharmova Q3FY21 consolidated PAT at Rs. 309.93 Cr

The company posted net profit of Rs.203.38 crores for the period ended December 31, 2019.


Pfizer registers Q3FY21 PAT at Rs. 141.24 Cr
News | February 06, 2021

Pfizer registers Q3FY21 PAT at Rs. 141.24 Cr

The company has posted net profit of Rs.397.06 crores for the 9 months period ended December 31, 2020.


GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr
News | February 06, 2021

GlaxoSmithKline Pharmaceuticals Q3FY21 consolidated PAT at Rs. 156.51 Cr

The company posted net loss of Rs. 661.16 crores for the period ended December 31, 2019.


Dr. Reddy's Laboratories reports Rs. 19.8 Cr PAT in Q3FY21
News | February 01, 2021

Dr. Reddy's Laboratories reports Rs. 19.8 Cr PAT in Q3FY21

The company has posted net profit of Rs.19.8 crores for the period ended December 31, 2020 as against net loss of Rs. 569.7 crores for the period ended December 31, 2019.


Sun Pharmaceutical Q3FY21 net profit at Rs. 1852.48 Cr
News | February 01, 2021

Sun Pharmaceutical Q3FY21 net profit at Rs. 1852.48 Cr

The company has reported total income of Rs.25699.68 crores during the 9 months period ended December 31, 2020.


CIPLA Q3 FY21 PAT up to Rs. 748.15 Cr
News | February 01, 2021

CIPLA Q3 FY21 PAT up to Rs. 748.15 Cr

The company has reported total income of Rs.14759 crores during the 9 months period ended December 31, 2020.